{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T20:08:42Z","timestamp":1766174922601,"version":"3.48.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xkme.2025.101134","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:26:47Z","timestamp":1760074007000},"page":"101134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Expanded Hemodialysis on Subjective Experience Using Dynamic Patient-Reported Outcome Measurement Tool"],"prefix":"10.1016","volume":"7","author":[{"given":"Jarrin D.","family":"Penny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariuz","family":"Gozdzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Tamasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Dorie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Koyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zabrina Bailey","family":"Lozon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Cesario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gihad","family":"Nesrallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher W.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xkme.2025.101134_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41581-021-00518-z","article-title":"Patient-centred approaches for the management of unpleasant symptoms in kidney disease","volume":"18","author":"Kalantar-Zadeh","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2025.101134_bib2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101134_bib3","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.xkme.2025.101134_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169024","article-title":"Medium cut-off (MCO) membranes reduce inflammation in chronic dialysis patients - a randomized controlled clinical trial","volume":"12","author":"Zickler","year":"2017","journal-title":"PLoS One"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2025.101134_bib5","doi-asserted-by":"crossref","first-page":"iii6","DOI":"10.1093\/ndt\/gfy179","article-title":"Large uremic toxins: an unsolved problem in end-stage kidney disease","volume":"33","author":"Wolley","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2025.101134_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000479262","article-title":"The rationale for expanded hemodialysis therapy (HDx)","volume":"191","author":"Hutchison","year":"2017","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.xkme.2025.101134_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000479254","article-title":"End-stage renal disease, inflammation and cardiovascular outcomes","volume":"191","author":"Dai","year":"2017","journal-title":"Contrib Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101134_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ndt\/gfw310","article-title":"Performance of hemodialysis with novel medium cut-off dialyzers","volume":"32","author":"Kirsch","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2025.101134_bib9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ckj\/sfy004","article-title":"Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration","volume":"11","author":"Garc\u00eda-Prieto","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.xkme.2025.101134_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000479267","article-title":"Effects of expanded hemodialysis therapy on clinical outcomes","volume":"191","author":"Mitra","year":"2017","journal-title":"Contrib Nephrol"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2025.101134_bib11","doi-asserted-by":"crossref","first-page":"iii48","DOI":"10.1093\/ndt\/gfy203","article-title":"Expanded haemodialysis: news from the field","volume":"33","author":"Florens","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2025.101134_bib12","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1159\/000476012","article-title":"The rise of expanded hemodialysis","volume":"44","author":"Ronco","year":"2017","journal-title":"Blood Purif"},{"issue":"5","key":"10.1016\/j.xkme.2025.101134_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/sdi.13071","article-title":"Hemodiafiltration (HDF) versus expanded hemodialysis (HDx)","volume":"35","author":"Maduell","year":"2022","journal-title":"Semin Dial"},{"issue":"2","key":"10.1016\/j.xkme.2025.101134_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ndt\/gfz189","article-title":"Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial","volume":"35","author":"Belmouaz","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2025.101134_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000468959","article-title":"Expanded hemodialysis: a new therapy for a new class of membranes","volume":"190","author":"Ronco","year":"2017","journal-title":"Contrib Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2025.101134_bib16","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2215\/CJN.01210120","article-title":"Efficacy and safety of expanded hemodialysis with the Theranova 400 dialyzer: a randomized controlled trial","volume":"15","author":"Weiner","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101134_bib17","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1038\/s41598-020-64622-z","article-title":"Randomized controlled trial of medium cut-off versus high-flux dialyzers on quality of life outcomes in maintenance hemodialysis patients","volume":"10","author":"Lim","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.xkme.2025.101134_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220448","article-title":"Long-term effect of medium cut-off dialyzer on middle uremic toxins and cell-free hemoglobin","volume":"14","author":"Cho","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xkme.2025.101134_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000508803","article-title":"Impact of medium cut-off dialyzers on patient-reported outcomes: COREXH registry","volume":"50","author":"Alarcon","year":"2021","journal-title":"Blood Purif"},{"issue":"1","key":"10.1016\/j.xkme.2025.101134_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41687-017-0010-9","article-title":"Methodological considerations in using patient reported measures in dialysis clinics","volume":"1","author":"Peipert","year":"2017","journal-title":"J Patient Rep Outcomes"},{"issue":"2","key":"10.1016\/j.xkme.2025.101134_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/sdi.13130","article-title":"Systematic review to compare the outcomes associated with the modalities of expanded hemodialysis (HDx) versus high-flux hemodialysis and\/or hemodiafiltration (HDF) in patients with end-stage kidney disease","volume":"36","author":"Mitchell","year":"2023","journal-title":"Semin Dial"},{"key":"10.1016\/j.xkme.2025.101134_bib22","article-title":"Clinical outcomes with medium cut-off versus high-flux hemodialysis membranes: a systematic review and meta-analysis","volume":"9","author":"Kandi","year":"2022","journal-title":"Can J Kidney Health Dis"},{"issue":"2","key":"10.1016\/j.xkme.2025.101134_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000513328","article-title":"Expanded hemodialysis and its effects on hospitalizations and medication usage: a cohort study","volume":"145","author":"Sanabria","year":"2021","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.xkme.2025.101134_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/hdi.13015","article-title":"Economic evaluation of expanded hemodialysis with the Theranova 400 dialyzer: a post hoc evaluation of a randomized clinical trial in the United States","volume":"26","author":"Blackowicz","year":"2022","journal-title":"Hemodial Int"},{"issue":"5","key":"10.1016\/j.xkme.2025.101134_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/1744-9987.13620","article-title":"An initial evaluation of expanded hemodialysis on hospitalizations, drug utilization, costs, and patient utility in Colombia","volume":"25","author":"Ariza","year":"2021","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.xkme.2025.101134_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.kint.2023.05.019","article-title":"Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"104","author":"Mehrotra","year":"2023","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.xkme.2025.101134_bib27","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.ekir.2023.08.025","article-title":"The role of nephrology nurses in symptom management \u2013 reflections on the Kidney Disease: Improving Global Outcomes Controversies Conference on symptom-based complications in dialysis care","volume":"8","author":"Ng","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.xkme.2025.101134_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/hdi.12470","article-title":"Collection of daily patient reported outcomes is feasible and demonstrates differential patient experience in chronic kidney disease","volume":"21","author":"Pittman","year":"2017","journal-title":"Hemodial Int"},{"issue":"6","key":"10.1016\/j.xkme.2025.101134_bib29","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.xkme.2021.05.010","article-title":"Impact of expanded hemodialysis using medium cut-off dialyzer on quality of life: application of dynamic patient-reported outcome measurement tool","volume":"3","author":"Penny","year":"2021","journal-title":"Kidney Med"},{"issue":"1","key":"10.1016\/j.xkme.2025.101134_bib30","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1111\/hdi.12885","article-title":"Pruritus: is there a grain of salty truth?","volume":"25","author":"Penny","year":"2021","journal-title":"Hemodial Int"},{"issue":"1","key":"10.1016\/j.xkme.2025.101134_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpainsymman.2019.08.013","article-title":"Stability and impact of symptom clusters in patients with end-stage renal disease undergoing dialysis","volume":"59","author":"Ng","year":"2020","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.xkme.2025.101134_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73124-x","article-title":"Medium cut-off dialyzer improves erythropoiesis stimulating agent resistance in a hepcidin-independent manner in maintenance hemodialysis patients: results from a randomized controlled trial","volume":"10","author":"Lim","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.xkme.2025.101134_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100431","article-title":"Medium cutoff versus high-flux hemodialysis membranes and clinical outcomes: a cohort study using inverse probability treatment weighting","volume":"4","author":"Molano","year":"2022","journal-title":"Kidney Med"},{"issue":"8","key":"10.1016\/j.xkme.2025.101134_bib34","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1681\/ASN.0000000655","article-title":"Expanded hemodialysis with Theranova dialyzer and residual kidney function in patients starting long-term hemodialysis: a randomized controlled trial","volume":"36","author":"Lim","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2025.101134_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/PROM.S325016","article-title":"Clinical assessment of dialysis recovery time and symptom burden: impact of switching hemodialysis therapy mode","volume":"12","author":"Bolton","year":"2021","journal-title":"Patient Relat Outcome Meas"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T20:07:06Z","timestamp":1766174826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2590059525001700"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101134","relation":{},"ISSN":["2590-0595"],"issn-type":[{"type":"print","value":"2590-0595"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Expanded Hemodialysis on Subjective Experience Using Dynamic Patient-Reported Outcome Measurement Tool","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101134"}}